Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RESMETIROM vs REZAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RESMETIROM vs REZAFUNGIN: Safety Overview

Metric RESMETIROM REZAFUNGIN
Total FAERS Reports 881 108
Deaths Reported 26 12
Death Rate 3.0% 11.1%
Hospitalizations 50 20
Average Patient Age 58.1 yrs 53.8 yrs
% Female Patients 65.3% 54.3%
FDA Approval Date Mar 14, 2024 Mar 22, 2023
Manufacturer Madrigal Pharmaceuticals, Inc. Melinta Therapeutics, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription